AUST WIDE RESTRICTED PAIRS 2024 (28-OCT-24)

Pair 8 NS - RACHEL WAGNER / LORRAINE REA
Place: 7, Percentage: 47.22%
Board No vs Pr ContractLeadResult  Score  Matchpoints%   
Board 16: HELEN HYLAND / FAYE SNELLING3C N9D91101372%  
Board 26: HELEN HYLAND / FAYE SNELLING2S N3C9140528%  
Board 36: HELEN HYLAND / FAYE SNELLING1S S3H6-50950%  
Board 45: DIVYESH SHAH / RINA SHAH3NT E9H9-600739%  
Board 55: DIVYESH SHAH / RINA SHAH4H NAC8-20016%  
Board 65: DIVYESH SHAH / RINA SHAH3NT N3D7-10000%  
Board 74: LESLEY SMITH / NEVIA MEDICA1S EKH9-1401478%  
Board 84: LESLEY SMITH / NEVIA MEDICA2H N3S8110317%  
Board 94: LESLEY SMITH / NEVIA MEDICA2S N8H91401478%  
Board 103: MIKE BENNETT / GILLIAN ELDER2D W2C62001689%  
Board 113: MIKE BENNETT / GILLIAN ELDER2C S3H9110844%  
Board 123: MIKE BENNETT / GILLIAN ELDER2NT W4H8-120422%  
Board 132: CHRISTINE MARTIN / KAYOKO BREDEMEYER3C NAS10130317%  
Board 142: CHRISTINE MARTIN / KAYOKO BREDEMEYER1NT N7S7901372%  
Board 152: CHRISTINE MARTIN / KAYOKO BREDEMEYER3NT W9D12-490633%  
Board 161: ELAINE PERRY / DAVID KING3H N9D91401478%  
Board 171: ELAINE PERRY / DAVID KING1NT S3C81201478%  
Board 181: ELAINE PERRY / DAVID KING4S WKC10-420422%  
Board 1910: PATRICIA STAPLEDON / VERA RODIN3NT S2D104301478%  
Board 2010: PATRICIA STAPLEDON / VERA RODIN3NT S2S8-100633%  
Board 2110: PATRICIA STAPLEDON / VERA RODIN3NT WJH9-4001689%  
Board 229: LORRAINE POYNTON / VALERIE HILDEBRAND4S NAH9-50211%  
Board 239: LORRAINE POYNTON / VALERIE HILDEBRAND3D WAH810018100%  
Board 249: LORRAINE POYNTON / VALERIE HILDEBRAND5DX EAS850018100%  
Board 258: JACQUES BELLEVRET / MARIO RUBANATHAN2S WQC8-11000%  
Board 268: JACQUES BELLEVRET / MARIO RUBANATHAN2S WQD9-140528%  
Board 278: JACQUES BELLEVRET / MARIO RUBANATHAN3H NQS91401583%  
Board 287: BRIAN EMBLETON / JULIE COATES2S WQC8-110317%  
Board 297: BRIAN EMBLETON / JULIE COATES2D S5H6-200317%  
Board 307: BRIAN EMBLETON / JULIE COATES2S WTC750739%  

Click on the Board Number to display that complete board, or click on a Pair to show that Pair's performance.

     Back to this session's results